Home » Topics » BioWorld Science

BioWorld Science
RSS

Celsion reports in vivo data on PLACCINE DNA vaccine platform against SARS-CoV-2

Sep. 3, 2021

Deficient H2A.Z deposition tied to uterine leiomyoma

Sep. 3, 2021

New kratom derivatives identified with mu-opioid receptor modulatory activity

Sep. 3, 2021

Variants in PI4KA linked to severe neurometabolic disorder

Sep. 3, 2021

AstraZeneca discloses adenosine receptor antagonists

Sep. 3, 2021

Stingray Therapeutics presents new ENPP1 inhibitors

Sep. 3, 2021

Haim Bio synthesizes new antiepileptics

Sep. 3, 2021

Bristol Myers Squibb presents PADI4 inhibitors

Sep. 3, 2021

AMMS patents carbonic anhydrase inhibitors

Sep. 3, 2021

Study identifies cell state as oncogene enabler

Sep. 3, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...